Search

everythinglearnresearchcommunity

for

Search:↓

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Eating a high-glycemic diet may worsen acne by increasing certain protein levels and expressions in the skin.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Cancer development is like natural selection, involving mutated cells and environmental factors.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Female hair loss linked to metabolic syndrome, not in males.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Hair loss may indicate higher heart risk and metabolic issues.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.